Arlington Partners LLC Biomarin Pharmaceutical Inc Transaction History

Arlington Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 13, 2020	SELL	$79.55 - $124.22 $6,443 - $10,061	-81 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$64.27 - $86.37 $5,205 - $6,995	81 New	81 $7,000
Q1 2019 Apr 05, 2019	SELL	$84.2 - $98.62 $6,820 - $7,988	-81 Closed	0 $0
Q4 2018 Jan 10, 2019	BUY	$80.14 - $106.07 $6,491 - $8,591	81 New	81 $7,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.